8-K
filed June 4, 2024, 7:59 PM ET
ticker BCLI
CIK 0001137883
regulatory
confidence high
sentiment negative
materiality 0.70
Nasdaq grants Brainstorm Cell Therapeutics temporary exception until Oct 21 for bid price compliance
BRAINSTORM CELL THERAPEUTICS INC.
- Company received delisting notice on May 1 for failing $1 minimum bid price; appealed on May 2.
- Nasdaq granted temporary exception until Oct 21, 2024; must comply by then or face delisting.
- If not compliant by mid-August 2024, must execute reverse stock split no later than Oct 7, 2024.
- No assurance reverse split will achieve compliance; delisting risk persists if deadline missed.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001104659-24-068007
- form_type
- 8-K
- ticker
- BCLI
- cik
- 0001137883
- company_name
- BRAINSTORM CELL THERAPEUTICS INC.
- filed_at
- 2024-06-04T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:17.425487+00:00
- generated_at
- 2026-06-01T06:27:47.563284+00:00
- sec_items
- ["3.01"]
- event_type
- regulatory
- sentiment
- negative
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001104659-24-068007
- json_url
- https://secwatch.observer/filing/0001104659-24-068007.json
- markdown_url
- https://secwatch.observer/filing/0001104659-24-068007.md
- text_url
- https://secwatch.observer/filing/0001104659-24-068007.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1137883/000110465924068007/0001104659-24-068007-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1137883/000110465924068007/tm2416355d1_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
ISPC
iSpecimen flagged for Nasdaq equity shortfall; equity $814K vs $2.5M minimum
iSpecimen Inc.
June 1, 2026, 5:00 PM ET
regulatory
Items 3.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
GENC
Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing
GENCOR INDUSTRIES INC
June 1, 2026, 4:09 PM ET
regulatory
Items 3.01, 7.01, 9.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
NUTR
NusaTrip receives Nasdaq delinquency notice for late 10-K and 10-Q; faces delisting if not compliant by Oct 12, 2026
NUSATRIP Inc
June 1, 2026, 7:10 AM ET
regulatory
Items 3.01, 9.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
XXI
Twenty One Capital receives NYSE non-compliance notice; audit committee lacks independence; cure due June 5
Twenty One Capital, Inc.
June 1, 2026, 7:05 AM ET
regulatory
Items 3.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
COLA
Columbus Acquisition regains compliance with Nasdaq $50M MVLS rule; delisting risk removed
Columbus Acquisition Corp/Cayman Islands
May 29, 2026, 9:56 PM ET
regulatory
Items 3.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
HWH
HWH International receives Nasdaq deficiency notice for equity below $2.5M threshold
HWH International Inc.
May 29, 2026, 5:21 PM ET
regulatory
Items 3.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
ATNM
Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26
Actinium Pharmaceuticals, Inc.
May 29, 2026, 5:10 PM ET
regulatory
Items 3.01, 7.01, 9.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
CSAI
Cloudastructure receives Nasdaq delinquency notice for late Q1 10-Q filing
CLOUDASTRUCTURE, INC.
May 29, 2026, 5:09 PM ET
regulatory
Items 3.01, 9.01
same SEC item: 3.01
same event type: regulatory
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.